Nadia Galizzi
Bergamo, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Cystic echinococcosis in the abdominal wall.
Journal: Journal of travel medicine
Published: June 19, 2023
Retrospective study on the outcome of two-drug regimens based on dolutegravir plus one reverse transcriptase inhibitor in virologically-suppressed HIV-infected patients.
Journal: International journal of antimicrobial agents
Published: April 15, 2019
Homeostatic model assessment for insulin resistance index trajectories in HIV-infected patients treated with different first-line antiretroviral regimens.
Journal: Journal of medical virology
Published: February 26, 2019
Glomerular filtration rate estimated by cystatin C formulas in HIV-1 patients treated with dolutegravir, rilpivirine or cobicistat.
Journal: The new microbiologica
Published: September 26, 2018
Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen.
Journal: International journal of antimicrobial agents
Published: February 02, 2018
Determinants of patient and health care services delays for tuberculosis diagnosis in Italy: a cross-sectional observational study.
Journal: BMC infectious diseases
Published: October 22, 2017
An observational, retrospective analysis evaluating switching to raltegravir plus abacavir/lamivudine in HIV-1-infected patients: the ORASWIRAL study.
Journal: Infectious diseases (London, England)
Published: September 12, 2017
Durability of switch regimens based on rilpivirine or on integrase inhibitors, both in association with tenofovir and emtricitabine, in HIV-infected, virologically suppressed patients.
Journal: BMC infectious diseases
Published: June 13, 2017
Survival and predictors of death in people with HIV-associated lymphoma compared to those with a diagnosis of lymphoma in general population.
Journal: PloS one
Published: May 31, 2017
Long-term efficacy and safety of rilpivirine plus abacavir and lamivudine in HIV-1 infected patients with undetectable viral load.
Journal: PloS one
Published: May 19, 2017
Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients.
Journal: The Journal of infection
Published: July 19, 2016
Last Updated: 09/26/2026